NPS Pharmaceuticals Inc. (NPSP) Profile

Profile for NPS Pharmaceuticals Inc. (NPSP)

After Hours: $ 7.41

0.00 (0.00%)

Volume: 1.23 k

4:27 PM EST Feb 10, 2012


Business Description: NPS Pharmaceuticals is engaged in the development of new treatment options for patients with rare gastrointestinal and endocrine disorders and serious unmet medical needs.

Address:	550 Hills Drive, Bedminster, NJ, 07921
Telephone:	(908) 450-5300	Website:	www.npsp.com
Facsimile:	(908) 450-5351	Email:	N/A


Details

CEO:	Dr. Francois Nader,M.D.
Employees:	63	Market Cap:	637.86 m
Issue Type:	CS
Auditor:	KPMG LLP
Last Audit:	Unqualified
Indices:	Biotechnology


Industry Classifications

Sector:	Healthcare	CIK:	0000890465
Industry:	Drugs
Sub-Industry:	Biotechnology
NAICS:	Biological Product (except Diagnostic) Manufacturing (325414)
SIC:	Biological Products, Except Diagnostic Substances (2836)

Tags for NPS Pharmaceuticals Inc.

Research stocks or mutual funds related to NPS Pharmaceuticals Inc. by keywords or tags. Find companies that have a similar focus to NPSP. The keywords below have been associated to NPSP by either user submission or electronic means.

schering plough health care products biotechnology company pharmaceuticals research pharmaceuticals international research king report on corporate governance corporate governance quotient elite pharmaceuticals pharmaceutical industry strategy biotech conference pharmaceutical market corporate governance consulting corporate governance training pharmaceuticals companies generic pharmaceutical pharmaceuticals logistics niche pharmaceutical investment products board of director biotechnology market pharmaceutical research and development corporate governance legislation annual report corporate governance committee charter new innovative products Biological Products corporate governance calpers corporate governance governance consultant pharma manufacturing governance consulting corporate governance practices pharmaceuticals jobs pfizer pharmaceutical company novartis pharmaceuticals kv pharmaceutical company pharmaceuticals supply chain corporate law warrick pharmaceutical corporate governance issues licensed products generic products corporate governance conference corporate governance ratings data monitoring committees pharmaceutical cro annual report printing pharma companies define corporate governance governance policy board of directors role

Financial Market Data powered by QuoteMedia.com. All rights reserved. View the Terms of Use
NYSE/AMEX data delayed 20 minutes. NASDAQ and other data delayed 15 minutes unless indicated.
RT Realtime, EOD End Of Day, PD Previous Day. PW Previous Week.

All information displayed and available herein is on an "as is", "as available" basis and neither InvestorPoint.com nor any of its underlying service providers, information providers, licensors, employees, distributors or agents make any representations as to the suitability of our service or the materials for any purpose. The information is not intended for trading purposes or advice. We specifically disclaim any representations or warranties, express or implied, including, without limitation, any representations or warranties of merchantability or fitness for a particular purpose. InvestorPoint.com is not an investment adviser. We do not: (a) give investment advice, (b) advocate the purchase or sale of any security or investment and (c) provide, endorse or review any information or data contained herein. We do not guarantee the accuracy of the information and data supplied by information providers. We are not liable or responsible for the quality, accuracy or reliability of this information. You should always seek the assistance of a professional for investment advice.